Key result
Elevated IL-1Ra levels independently predict incident type 2 diabetes as a marker of metabolic dysregulation.
IL-1Ra represents a promising biomarker for early identification of insulin resistance and long-term prediction of incident type 2 diabetes.
Answers are grounded in this paper and cite their sources.
IL-1Ra may aid early T2DM risk stratification; leaves open added clinical value pending prospective validation.
Low-grade inflammation is a major player in obesity and the metabolic syndrome predicting development of type 2 diabetes (T2DM). The interleukin-1 receptor antagonist (IL-1Ra) is a vital and natural anti-inflammatory factor and mediator in glucose homeostasis disturbances. The predictive role is independent of multiple confounders, and elevated levels appear few years before T2DM. The role of IL-1Ra is important for accumulated risk factors, dysregulated metabolism and glucose homeostasis, and dietary interventions. Longitudinal and cross-sectional population study cohorts have enabled the approximation of IL-1Ra limit values for metabolic dysregulation and guide further analysis as a potential biomarker. The limit value of IL-1Ra is reaching 400 pg/mL with prediabetes and before T2DM. However, subjects with metabolic syndrome are suggested to have lower limit values, especially among men. Future research may evaluate the role of IL-1Ra in actual glucose homeostasis together with routine fasted laboratory tests, such as glucose and C-reactive protein (CRP) instead of the oral glucose tolerance test. The significance of intermediate low IL-1Ra levels in metabolic abnormalities should be further analyzed. It is possible to specify the impact of multiple lifestyle and metabolic parameters together with age and sex. IL-1Ra could be studied in multiple approaches including interventional studies of metabolic diseases.
No takes yet. Share an insight, caveat, or question.
Kari Luotola (2022) conducted a review in Metabolic disorders and type 2 diabetes. IL-1Ra levels was evaluated. Elevated levels of IL-1Ra predict the development of type 2 diabetes independently of classical risk factors and could serve as a biomarker for metabolic dysregulation.
Synapse has enriched 10 related papers. Consider them for comparative context: